Pires NM - Search Results

1

Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff.

Pires NM, van der Hoeven BL, de Vries MR, Havekes LM, van Vlijmen BJ, Hennink WE, Quax PH, Jukema JW. Pires NM, et al. Biomaterials. 2005 Sep;26(26):5386-94. doi: 10.1016/j.biomaterials.2005.01.063. Biomaterials. 2005. PMID: 15814137

2

Drug-eluting stents: results, promises and problems.

van der Hoeven BL, Pires NM, Warda HM, Oemrawsingh PV, van Vlijmen BJ, Quax PH, Schalij MJ, van der Wall EE, Jukema JW. van der Hoeven BL, et al. Among authors: pires nm. Int J Cardiol. 2005 Mar 10;99(1):9-17. doi: 10.1016/j.ijcard.2004.01.021. Int J Cardiol. 2005. PMID: 15721493 Review.

3

Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries.

Pires NM, Schepers A, van der Hoeven BL, de Vries MR, Boesten LS, Jukema JW, Quax PH. Pires NM, et al. Cardiovasc Res. 2005 Dec 1;68(3):415-24. doi: 10.1016/j.cardiores.2005.06.015. Epub 2005 Jul 15. Cardiovasc Res. 2005. PMID: 16023630

4

Drug-eluting stents studies in mice: do we need atherosclerosis to study restenosis?

Pires NM, Jukema JW, Daemen MJ, Quax PH. Pires NM, et al. Vascul Pharmacol. 2006 May;44(5):257-64. doi: 10.1016/j.vph.2006.01.011. Epub 2006 Mar 9. Vascul Pharmacol. 2006. PMID: 16527546 Review.

5

Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.

Pires NM, Eefting D, de Vries MR, Quax PH, Jukema JW. Pires NM, et al. Heart. 2007 Aug;93(8):922-7. doi: 10.1136/hrt.2006.102244. Epub 2007 Apr 20. Heart. 2007. PMID: 17449502 Free PMC article.

6

Tumor necrosis factor-alpha plays an important role in restenosis development.

Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, 't Hart LM, Frants RR, Quax PH, van Vlijmen BJ, Havekes LM, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: pires nm. FASEB J. 2005 Dec;19(14):1998-2004. doi: 10.1096/fj.05-4634com. FASEB J. 2005. PMID: 16319143

7

Local Cre-mediated gene recombination in vascular smooth muscle cells in mice.

Zadelaar SM, Boesten LS, Pires NM, van Nieuwkoop A, Biessen EA, Jukema W, Havekes LM, van Vlijmen BJ, Willems van Dijk K. Zadelaar SM, et al. Among authors: pires nm. Transgenic Res. 2006 Feb;15(1):31-6. doi: 10.1007/s11248-005-3226-z. Transgenic Res. 2006. PMID: 16475008

8

Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice.

Schepers A, Pires NM, Eefting D, de Vries MR, van Bockel JH, Quax PH. Schepers A, et al. Among authors: pires nm. J Vasc Surg. 2006 Apr;43(4):809-15. doi: 10.1016/j.jvs.2005.11.019. J Vasc Surg. 2006. PMID: 16616241 Free article.

9

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice.

Eefting D, Schepers A, De Vries MR, Pires NM, Grimbergen JM, Lagerweij T, Nagelkerken LM, Monraats PS, Jukema JW, van Bockel JH, Quax PH. Eefting D, et al. Among authors: pires nm. Atherosclerosis. 2007 Aug;193(2):335-42. doi: 10.1016/j.atherosclerosis.2006.09.032. Epub 2006 Nov 7. Atherosclerosis. 2007. PMID: 17087966

10

Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists.

Krom YD, Pires NM, Jukema JW, de Vries MR, Frants RR, Havekes LM, van Dijk KW, Quax PH. Krom YD, et al. Among authors: pires nm. Cardiovasc Res. 2007 Jan 1;73(1):217-26. doi: 10.1016/j.cardiores.2006.10.024. Epub 2006 Nov 10. Cardiovasc Res. 2007. PMID: 17141206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page